Choe 2005.

Study characteristics
Methods	Proactive case management of high‐risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial Patient RCT, conducted in an university affiliated primary care internal medicine clinic, USA Two arms: 1) Control (control arm) and 2) Intervention (intervention arm)
Participants	Control arm N: 39 Intervention arm N: 41 Diabetes type: type 2 Mean age: 51.6 ± 10.1 % Male: 47.5 Longest follow‐up: 24 months
Interventions	Control arm: None Intervention arm: 1) Case management 2) Team changes 3) Patient education 4) Promotion of self‐management
Outcomes	1) Retinopathy screening (eye exam), N screened (%) Control arm: pre NR (NR), post 26 (74) Intervention arm: pre NR (NR), post 38 (97) 2) Foot screening, N screened (%) Control arm: pre NR (NR), post 22 (63) Intervention arm: pre NR (NR), post 36 (92) 3) HbA1c, mean % (SD) Control arm: pre 10.2 (1.7), post 9.3 (2.1) Intervention arm: pre 10.1 (1.8), post 8.0 (1.4)
Funding source	Funding for the clinical pharmacist was provided by the University of Michigan College of Pharmacy
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	Information not available.
Allocation concealment (selection bias)	High risk	Information not available.
Patient's baseline characteristics (selection bias)	Low risk	Information not available.
Patient's baseline outcomes (selection bias)	Low risk	Information not available.
Incomplete outcome data (attrition bias)	Low risk	Information not available.
Blinding of participants and personnel (performance bias) and of outcome assessors (detection bias)	Low risk	Information not available.
Selective reporting (reporting bias)	Low risk	Information not available.
Risk of contamination (other bias)	Low risk	Information not available.
Other bias	Low risk	Information not available.